The First Medical Device to Receive National Biotechnology and Medical Care Quality Award - Silver Award: APrevent achieves a New Milestone!
APrevent proudly announces that its flagship product, VOIS Implant, has been honored with the 2024 Biotechnology and Medical Care Quality Award - Silver Award. This prestigious recognition highlights the company’s commitment to advancing patient care through groundbreaking medical technologies.
2025-01-21
APrevent won 2024 MedTech Innovator Asia Pacific Grand Finals
APrevent recently achieved a significant milestone by winning the prestigious 2024 MedTech Innovator Asia Pacific Grand Finals.
2024-09-13
APrevent Medical Inc. Secures $6 Million in Series D Funding Led by Taiwania Capital
APrevent Medical Inc. is thrilled to announce the successful Series D funding round led by Taiwania Capital, a leading venture capital firm in Taiwan , backed by Taiwan’s public and private sectors which focus on investing in innovative companies in High-tech and Biotech fields.
2024-03-29
APrevent VOIS receives 2024 German NUB subsidy
APrevent VOIS, with its features of post-operative adjustment and standardized surgical procedures, effectively reduces the consumption of medical resources and provides high cost-effectiveness, has won the 2024 German New Medical Technology Additional Payment (NUB) subsidy.
2024-02-06